Skip to main content
Equibles
RNA $10.36 +0.10%
RNA logo
RNA · Atrium Therapeutics, Inc.
Track RNA — free

Use RNA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RNA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$10.36 +0.01 (+0.10%) At close · Sep 11
Russell 2000 member Rebalance outlook locked
Market Cap
$177.21M
Shares
17.11M
All earnings calls

Earnings call · FY2026 Q2

Atrium Therapeutics, Inc. (RNA) Q2 2026 Earnings Call

Concluded Aug 13, 2026
Aug 13, 2026 0 turns
Period
FY2026 Q2
Runtime
—
Sources
3 artifacts
Slides 8 8-K 10-Q

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. slides, 8-K earnings release, 10-Q stay in one workspace.

Research coverage

3 live sources

Open each available source without leaving this research workspace.

Revenue $3.00M -21.9% YoY
Diluted EPS -$1.18
Net income -$20.19M

Research materials

Open the source you need; every reader stays inside this workspace.

Presentation 8 pages 8-K earnings release Filed Aug 13, 2026 10-Q report Filed Aug 13, 2026 Company webcastOpen the original investor-relations page
Full-screen source Call document

RNA transcript alerts

Atrium Therapeutics, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →